XML 81 R67.htm IDEA: XBRL DOCUMENT v3.22.4
Goodwill and Intangible Assets - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Intangible Assets [Line Items]        
Decrease in goodwill   $ 18 $ 2  
Accumulated goodwill impairment losses   0    
Aggregate amortization expense related to finite-lived intangible assets   $ 1,800 $ 1,700 $ 1,200
Discount rate of acquired IPR&D   7.50% 6.50% 8.00%
In-process research and development impairment   $ 2,700 $ 0 $ 0
In Process Research And Development Trodelvy For HR+/HER2-        
Intangible Assets [Line Items]        
Indefinite-lived intangible assets, fair value $ 6,100 6,100    
In Process Research And Development Trodelvy For HR+/HER2- | Fair Value, Nonrecurring        
Intangible Assets [Line Items]        
In-process research and development impairment 2,700 2,700    
MYR        
Intangible Assets [Line Items]        
Decrease in goodwill $ 18 $ 18    
Immunomedics, Inc. | In Process Research And Development Trodelvy For HR+/HER2-        
Intangible Assets [Line Items]        
Aggregate fair value of acquired IPR&D       $ 8,800
Immunomedics, Inc. | In Process Research And Development Trodelvy For HR+/HER2- | Measurement Input, Discount Rate        
Intangible Assets [Line Items]        
Discount rate, measurement input 6.75%